Puleco Stock Bar’s stock code 603566 is not a GEM listed company. The GEM stock code starts with 300. It is a listed company on the Shanghai Stock Exchange and has continued to reach new lows. Be cautious and do not participate. Hunan Pleco Biological Products Co., Ltd. is a limited liability company (natural person investment or holding) registered in Yuhua District, Changsha City, Hunan Province on October 18, 2017. The registered address is located at Changsha Avenue, Yuhua District, Changsha City. Room 411, 4th Floor, Information Building, Hunan Provincial Animal Disease Prevention and Control Center, No. 708. The unified social credit code/registration number of Hunan Pleco Biological Products Co., Ltd. is 91430111MA4M6R6T6J. The legal person of the company is Li Shunli. The company is currently in business. Hunan Pleco Biological Products Co., Ltd., within this province, the current registered capital of the company is average.
1. Pleco Bioengineering Co., Ltd. is a high-tech enterprise engaged in the research, development, production and sales of veterinary biological products and chemicals. Its main products include veterinary biological products and chemicals, which are mainly used For the prevention and treatment of epidemic diseases in poultry and livestock. Among them, veterinary biological products are mainly various types of vaccines and antibodies, which are used to prevent and control the infection of poultry and livestock against epidemic diseases; veterinary chemicals are mainly used to treat livestock and poultry diseases. Various diseases.
2. Introduction: *** China’s first inactivated porcine circovirus type 2 vaccine *** National designated manufacturer of highly pathogenic porcine PRRS vaccine *** National Veterinary Drug Engineering Technology The research center is supported by the unit *** The first GMP microcarrier cell suspension culture production line in China *** Top 10 veterinary biological products manufacturers Pleco Bioengineering Co., Ltd. is engaged in the research and development, production and operation of veterinary biological products and drugs. The main business is a representative brand enterprise in my country's veterinary drug industry. It has three wholly-owned subsidiaries: Luoyang Huizhong Veterinary Drug Co., Ltd., Henan Xinzhao Bioengineering Co., Ltd., and Luoyang Huizhong Biotechnology Co., Ltd. The company has the only national veterinary drug engineering technology research center approved to be established by an enterprise in my country's veterinary drug industry. It has a national postdoctoral research station and an academician workstation. It currently has 169 technical R&D personnel, mainly with doctorates and masters. . The company has successively hosted the national "863" project, science and technology support plan and other projects, and successfully developed the world's first chicken new tributary (H9) triple and quadruple inactivated vaccine, China's first porcine circovirus type 2 inactivated vaccine and other 19 national-level products. For new vaccines and new veterinary drugs, we have applied for 259 national invention patents, formulated 41 national standards, and won more than 10 major scientific and technological achievement awards. Our comprehensive strength leads the industry.